Similar Papers

Paper Title
Journal
Date
Author
OP0029 The Risk of Serious Infections in Patients Receiving Rituximab for Rheumatoid Arthritis
L Silva-Fernandez ... K.D Watson
Annals of the Rheumatic Diseases | VOL. 73
L Silva-Fernandez, et. al.L Silva-Fernandez ... K.D Watson
01 Jun 2014
The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis.
Lucía Silva-Fernández ... Mark Lunt
Rheumatology | VOL. 55
Lucía Silva-Fernández, et. al.Lucía Silva-Fernández ... Mark Lunt
22 Aug 2016
The State of Periodontal Tissues in Patients with Rheumatoid Arthritis Who Live in Environmentally Unfavourable Areas
Khrystyna Kovalyshyn ... Tetiana Dmytryshyn
Galician Medical Journal | VOL. 26
Khrystyna Kovalyshyn, et. al.Khrystyna Kovalyshyn ... Tetiana Dmytryshyn
28 Dec 2019
Ustekinumab does not increase risk of new or recurrent cancer in inflammatory bowel disease patients with prior malignancy.
Badar Hasan ... Kanwarpreet Singh Tandon
Journal of Gastroenterology and Hepatology | VOL. 37
Badar Hasan, et. al.Badar Hasan ... Kanwarpreet Singh Tandon
10 Mar 2022
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Greetings from the Editor – 2025
Josef Smolen
Annals of the Rheumatic Diseases | VOL. -
Josef SmolenJosef Smolen
01 Jan 2025
Bridging the gap: tackling the challenge of limited progressors in clinical trials aimed at slowing the transition from early preradiographic to established osteoarthritis
Francis Berenbaum ... Marc Buyse
Annals of the Rheumatic Diseases | VOL. 84
Francis Berenbaum, et. al.Francis Berenbaum ... Marc Buyse
01 Jan 2025
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the rheumatic diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
20 Dec 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the Rheumatic Diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
19 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.